Vaccine trials in melanoma-time for reflection

Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)


The disappointing results of the large, randomized, controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.
Original languageUndefined/Unknown
Pages (from-to)256-258
Number of pages3
JournalNature Reviews Clinical Oncology
Issue number5
Publication statusPublished - 2009

Research programs

  • EMC MM-03-47-11

Cite this